Fig. 2From: The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision makingMost commonly prescribed neoadjuvant chemotherapy regimes according to disease subtype. a HER2 positive cancer b Triple negative breast cancer (TNBC) c Hormone receptor positive, HER2 negativeBack to article page